1. A 35-year-old man is found to have positive hepatitis B surface antigen (HBsAg) and positive hepatitis B e antigen (HBeAg) on routine screening. Which of the following is the most appropriate next step in management?
A. Initiate treatment with pegylated interferon
B. Initiate treatment with entecavir
C. Initiate treatment with lamivudine
D. Recommend hepatitis B vaccination for close contacts
E. Recommend liver transplantation
2. A 45-year-old woman with chronic hepatitis B presents with decompensated cirrhosis. Her laboratory values show elevated bilirubin, prolonged prothrombin time, and thrombocytopenia. Which of the following is the most appropriate management?
A. Initiate treatment with pegylated interferon
B. Initiate treatment with entecavir
C. Initiate treatment with lamivudine
D. Recommend hepatitis B vaccination for close contacts
E. Recommend liver transplantation
3. A 30-year-old man is found to have positive HBsAg, negative HBeAg, and normal ALT levels on routine screening. Which of the following is the most appropriate management?
A. Initiate treatment with pegylated interferon
B. Initiate treatment with entecavir
C. Initiate treatment with lamivudine
D. Recommend hepatitis B vaccination for close contacts
E. Recommend periodic monitoring
4. A 50-year-old woman with chronic hepatitis B presents with symptoms of decompensated cirrhosis, including ascites and hepatic encephalopathy. Her laboratory values show elevated bilirubin, prolonged prothrombin time, and thrombocytopenia. Which of the following is the most appropriate management?
A. Initiate treatment with pegylated interferon
B. Initiate treatment with entecavir
C. Initiate treatment with lamivudine
D. Recommend hepatitis B vaccination for close contacts
E. Recommend liver transplantation
5. A 40-year-old man is found to have positive HBsAg, positive HBeAg, and elevated ALT levels on routine screening. Which of the following is the most appropriate next step in management?
A. Initiate treatment with pegylated interferon
B. Initiate treatment with entecavir
C. Initiate treatment with lamivudine
D. Recommend hepatitis B vaccination for close contacts
E. Recommend periodic monitoring
6. A 55-year-old woman with chronic hepatitis B presents with decompensated cirrhosis, including ascites and hepatic encephalopathy. Her laboratory values show elevated bilirubin, prolonged prothrombin time, and thrombocytopenia. Which of the following is the most appropriate management?
A. Initiate treatment with pegylated interferon
B. Initiate treatment with entecavir
C. Initiate treatment with lamivudine
D. Recommend hepatitis B vaccination for close contacts
E. Recommend liver transplantation
7. A 35-year-old man is found to have positive HBsAg, negative HBeAg, and normal ALT levels on routine screening. Which of the following is the most appropriate management?
A. Initiate treatment with pegylated interferon
B. Initiate treatment with entecavir
C. Initiate treatment with lamivudine
D. Recommend hepatitis B vaccination for close contacts
E. Recommend periodic monitoring
8. A 45-year-old woman with chronic hepatitis B presents with decompensated cirrhosis, including ascites and hepatic encephalopathy. Her laboratory values show elevated bilirubin, prolonged prothrombin time, and thrombocytopenia. Which of the following is the most appropriate management?
A. Initiate treatment with pegylated interferon
B. Initiate treatment with entecavir
C. Initiate treatment with lamivudine
D. Recommend hepatitis B vaccination for close contacts
E. Recommend liver transplantation
9. A 30-year-old man is found to have positive HBsAg, positive HBeAg, and elevated ALT levels on routine screening. Which of the following is the most appropriate next step in management?
A. Initiate treatment with pegylated interferon
B. Initiate treatment with entecavir
C. Initiate treatment with lamivudine
D. Recommend hepatitis B vaccination for close contacts
E. Recommend periodic monitoring
10. A 50-year-old woman with chronic hepatitis B presents with symptoms of decompensated cirrhosis, including ascites and hepatic encephalopathy. Her laboratory values show elevated bilirubin, prolonged prothrombin time, and thrombocytopenia. Which of the following is the most appropriate management?
A. Initiate treatment with pegylated interferon
B. Initiate treatment with entecavir
C. Initiate treatment with lamivudine
D. Recommend hepatitis B vaccination for close contacts
E. Recommend liver transplantation
11. A 40-year-old man is found to have positive HBsAg, negative HBeAg, and normal ALT levels on routine screening. Which of the following is the most appropriate management?
A. Initiate treatment with pegylated interferon
B. Initiate treatment with entecavir
C. Initiate treatment with lamivudine
D. Recommend hepatitis B vaccination for close contacts
E. Recommend periodic monitoring
12. A 55-year-old woman with chronic hepatitis B presents with decompensated cirrhosis, including ascites and hepatic encephalopathy. Her laboratory values show elevated bilirubin, prolonged prothrombin time, and thrombocytopenia. Which of the following is the most appropriate management?
A. Initiate treatment with pegylated interferon
B. Initiate treatment with entecavir
C. Initiate treatment with lamivudine
D. Recommend hepatitis B vaccination for close contacts
E. Recommend liver transplantation
13. A 35-year-old man is found to have positive HBsAg, positive HBeAg, and elevated ALT levels on routine screening. Which of the following is the most appropriate next step in management?
A. Initiate treatment with pegylated interferon
B. Initiate treatment with entecavir
C. Initiate treatment with lamivudine
D. Recommend hepatitis B vaccination for close contacts
E. Recommend periodic monitoring
14. A 45-year-old woman with chronic hepatitis B presents with decompensated cirrhosis, including ascites and hepatic encephalopathy. Her laboratory values show elevated bilirubin, prolonged prothrombin time, and thrombocytopenia. Which of the following is the most appropriate management?
A. Initiate treatment with pegylated interferon
B. Initiate treatment with entecavir
C. Initiate treatment with lamivudine
D. Recommend hepatitis B vaccination for close contacts
E. Recommend liver transplantation
15. A 30-year-old man is found to have positive HBsAg, negative HBeAg, and normal ALT levels on routine screening. Which of the following is the most appropriate management?
A. Initiate treatment with pegylated interferon
B. Initiate treatment with entecavir
C. Initiate treatment with lamivudine
D. Recommend hepatitis B vaccination for close contacts
E. Recommend periodic monitoring